Gad Lavie

1.3k total citations
33 papers, 1.1k citations indexed

About

Gad Lavie is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gad Lavie has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gad Lavie's work include Photodynamic Therapy Research Studies (6 papers), Cancer therapeutics and mechanisms (5 papers) and Immunotherapy and Immune Responses (3 papers). Gad Lavie is often cited by papers focused on Photodynamic Therapy Research Studies (6 papers), Cancer therapeutics and mechanisms (5 papers) and Immunotherapy and Immune Responses (3 papers). Gad Lavie collaborates with scholars based in Israel and United States. Gad Lavie's co-authors include Daniel Meruelo, Mathilda Mandel, Yehuda Mazur, David Lavie, Michael Blank, Yona Keisari, Tilda Barliya, Brandi Levin, Dalia Freeman and J Pinkhas and has published in prestigious journals such as PLoS ONE, Cancer and Analytical Biochemistry.

In The Last Decade

Gad Lavie

31 papers receiving 1.0k citations

Peers

Countries citing papers authored by Gad Lavie

Since Specialization

Citations

This map shows the geographic impact of Gad Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gad Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gad Lavie more than expected).

Fields of papers citing papers by Gad Lavie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gad Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gad Lavie. The network helps show where Gad Lavie may publish in the future.

Co-authorship network of co-authors of Gad Lavie

This figure shows the co-authorship network connecting the top 25 collaborators of Gad Lavie. A scholar is included among the top collaborators of Gad Lavie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gad Lavie. Gad Lavie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS 2013 ·NeuroMolecular Medicine ·Jun‐Ho Lee, (unknown), (unknown), Mohamed R. Mughal, (unknown), (unknown), Arnell Carter, Ana Lustig, Omri Snir, Gad Lavie, Eitan Okun, Mark P. Mattson, Benjamin Sredni, Dennis D. Taub	13
2	Unique Anti-Glioblastoma Activities of Hypericin Are at the Crossroad of Biochemical and Epigenetic Events and Culminate in Tumor Cell Differentiation 2013 ·PLoS ONE ·(unknown), Mathilda Mandel, Gad Lavie	19
3	Degradation of HIF-1alpha under Hypoxia Combined with Induction of Hsp90 Polyubiquitination in Cancer Cells by Hypericin: a Unique Cancer Therapy 2011 ·PLoS ONE ·Tilda Barliya, Mathilda Mandel, Tami Livnat, Dov Weinberger, Gad Lavie	40
4	Clone clusters in autoreactive CD4 T‐cell lines from probable multiple sclerosis patients form disease‐characteristic signatures 2009 ·Immunology ·Mathilda Mandel, Anat Achiron, Tamir Tuller, Tilda Barliya, Gideon Rechavi, Ninette Amariglio, Ron Loewenthal, Gad Lavie	8
5	Advances in Microbial Biofilm Prevention on Indwelling Medical Devices with Emphasis on Usage of Acoustic Energy 2009 ·Sensors ·(unknown), Mathilda Mandel, (unknown), Gad Lavie	43
6	Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells 2008 ·Acta Oncologica ·(unknown), Tamar Fisher, (unknown), J. Shoham, Ruth Gallily, Raphael Mechoulam, Gad Lavie, Ninette Amariglio, Gideon Rechavi, Amos Toren	47
7	Mechanisms Operative in the Antitumor Activity of Temozolomide in Glioblastoma Multiforme 2007 ·The Cancer Journal ·Tamar Fisher, (unknown), Gad Lavie, Jasmine Jacob‐Hirsch, (unknown), Sharon Zeligson, Robert Winkler, Anthony Simon, Ninette Amariglio, Gideon Rechavi, Amos Toren	29
8	Unique Gene Expression Patterns in Human T‐cell Lines Generated from Multiple Sclerosis Patients by Stimulation with a Synthetic MOG Peptide 2005 ·Journal of Immunology Research ·Mathilda Mandel, Michael Gurevich, Gad Lavie, Irun R. Cohen, Anat Achiron	7
9	Anti-Angiogenic Activities of Hypericin in vivo: Potential for Ophthalmologic Applications 2005 ·Angiogenesis ·Gad Lavie, Mathilda Mandel, (unknown), Tilda Barliya, Michael Blank, (unknown), Daniel Meruelo, A Solomon	27
10	Competitive Quenching: A Possible Novel Approach in Protecting RPE Cells from Damage During PDT 2005 ·Current Eye Research ·Dov Weinberger, (unknown), Moshe Lusky, (unknown), Arie Orenstein, Michael Blank, Mathilda Mandel, (unknown), Tilda Barliya, Gad Lavie	5
11	Antimetastatic activity of the photodynamic agent hypericin in the dark 2004 ·International Journal of Cancer ·Michael Blank, Gad Lavie, Mathilda Mandel, (unknown), Arie Orenstein, Daniel Meruelo, Yona Keisari	41
12	Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases 2000 ·International Immunology ·Gad Lavie, Daniel Meruelo, (unknown), Mathilda Mandel	13
13	The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities 1995 ·Medicinal Research Reviews ·Gad Lavie, Yehuda Mazur, David Lavie, Daniel Meruelo	153
14	Photodynamic Inactivation of Radiation Leukemia Virus Produced from Hypericin-Treated Cells 1993 ·Virology ·(unknown), Gad Lavie, Daniel Meruelo	14
15	Inactivation of the Human Immunodeficiency Virus by Hypericin: Evidence for Photochemical Alterations of p24 and a Block in Uncoating 1992 ·AIDS Research and Human Retroviruses ·(unknown), Alfred M. Prince, Donna Pascual, Gad Lavie, Brandi Levin, Yehuda Mazur, David Lavie, Lorna S. Ehrlich, (unknown), Daniel Meruelo	59
16	A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography 1991 ·Analytical Biochemistry ·Leonard Liebes, Yehuda Mazur, Dalia Freeman, David Lavie, Gad Lavie, (unknown), Sandra Mendoza, Brandi Levin, Howard S. Höchster, Daniel Meruelo	67
17	Hypericin as an Antiretroviral Agent 1990 ·Annals of the New York Academy of Sciences ·Gad Lavie, Yehuda Mazur, David Lavie, Brandi Levin, Yitzhak Ittah, Daniel Meruelo	9
18	Cell surface-associated proteinases in NK cell-mediated cytotoxicity: Enhancement of enzyme expression is unique to activation with interferon-α 1989 ·Cellular Immunology ·Gad Lavie, (unknown)	1
19	The leukergy test in rheumatic diseases. New implications for an old test 1985 ·Arthritis & Rheumatism ·Shlomo Berliner, (unknown), N. Kariv, Abraham Weinberger, Michael Yaron, Gad Lavie, J Pinkhas, Moshe Aronson	22
20	Current concepts of the structure and pathogenesis of the amyloid diseases 1980 ·La Ricerca in Clinica e in Laboratorio ·Edward C. Franklin, Gad Lavie, Dorothea Zucker‐Franklin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact